Eur Rev Med Pharmacol Sci 2020; 24 (18): 9235-9235
DOI: 10.26355/eurrev_202009_22989

The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction

S. Zhang, R. Cui

Department of Cardiology, Heilongjiang Provincial Hospital, Harbin, Heilongjiang, P.R. China.


Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction, by S. Zhang, R. Cui, published in Eur Rev Med Pharmacol Sci 2018; 22 (2): 523-531–DOI: 10.26355/eurrev_201801_14205–PMID: 29424913” has been withdrawn.

 

The Publisher apologizes for any inconvenience this may cause.

The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction

Free PDF Download

To cite this article

S. Zhang, R. Cui
The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 18
Pages: 9235-9235
DOI: 10.26355/eurrev_202009_22989